As of Jul 28
| +0.60 / +1.86%|
The 6 analysts offering 12-month price forecasts for Depomed Inc have a median target of 30.50, with a high estimate of 34.00 and a low estimate of 26.00. The median estimate represents a -7.27% decrease from the last price of 32.89.
The current consensus among 6 polled investment analysts is to Buy stock in Depomed Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.